Gloucester Pharmaceuticals - Top 20 VC deals of 2008

Company: Gloucester Pharmaceuticals
Based: Cambridge, MA
Amount: $47.13M

Investors: Prospect Venture Partners, Individuals, ProQuest Investments, CIBC Capital Partners, Undisclosed Firm

Scoop: Gloucester Pharmaceuticals acquires clinical-stage oncology drug candidates and advances them through regulatory approval and commercialization. It's most advanced drug program is romidepsin, a histone deacetylase (HDAC) inhibitor in Phase III trials for T-cell lymphomas.